Digital Therapeutics business, market access and reimbursement strategy consulting servicesDTxCC guides clients through Business strategy review and development, Market access / Reimbursement strategy designs, execution and payer customer interface activities

DTxCC is proud to be named a Resource Partner of the Digital Therapeutic Alliance

Heali AI is a team led by serial entrepreneurs, PhD engineers, and ex-Google, Amazon and Snapchatters. Heali's mission is to make personalized dieting simple. We’re using a suite of technologies including Optical Character Recognition (OCR), Augmented Reality (AR) and Machine Learning AI to power a unique set of tools for consumers that will make their lives healthier.

Soundable Health is a digital health company with AI-enabled technology that uses sounds from patients to prevent diseases and monitor their health conditions.

D2 Pharma Consulting (D2) is a best-in-class consulting company exclusively focused on serving the life sciences industry. D2 assists emerging and established pharmaceutical, biopharmaceutical and medical device manufacturers to develop and execute strategic business initiatives, ensuring successful launch, distribution and reimbursement to support an ongoing leadership position in the marketplace. D2’s reach includes the US, Canada, Puerto Rico and over 20 European markets.

We work with small pharma organizations and digital therapeutics companies:We specialize in managed care and market access strategy Payer environmental analysis

Extended Schooner Consulting contract: Responsible for entire US and rest-of-world marketing and sales functionsKORU (Formerly RMS Medical products) is a leading developer and manufacturer of medical devices and supplies. Key accomplishments:• Increased sales by 26.4%• Company net income improved by 65.1% driven by strong sales• Restructured sales and marketing team• Replaced outdated CRM system with SalesForce.com• Implemented new incentive based contracting strategy to drive resultsRMS manufactures medical devices used in emergency care, hospital settings, nursing homes, other medical facilities and home care. The company's principal products are the FREEDOM60® Syringe Infusion System and the RES-Q-VAC® Emergency Medical Suction System. Additionally,the company markets it's HIgH-Flo Subcutaneous Needle Sets™ in the U.S.

Strategically focused on developing new sources of revenue by identifying and leading the execution of business partnerships designed to compliment TSI Healthcare NextGen specialty-specific Electronic Health Record (EHR/EMR), Enterprise Practice Management (EPM) and Revenue Cycle Management (RCM) platforms, enhance client service offerings, and expand market presence and TSI Rheumatology vertical market share. Create entirely new analytics and consulting business unit servicing the Pharma industry and related healthcare business sectors.Success Highlights:Successfully negotiated and executed co-marketing partnership with a prominent national lab service company. Partnership agreement projected to increase revenue by over $1.2MM annually

Adjunct Assistant Professor in Pharmaceutical and Healthcare Business MBA Program

Successfully executed market development and launch of powerful, high-performance Electronic Health Record (EHR/EMR), Revenue Cycle Management and specialty-specific practice management tools. These tools allow physician group practices to measure patient outcomes, manage buy-and-bill infusion business and increase reimbursement and billing efficiencies.Offerings include: - Web-based revenue cycle management tools designed to manage submission and collection of insurance claims - Web-based Infusion suite inventory, scheduling and billing management tool - iPad based EHR and practice management platform - Also successfully negotiated $23MM drug distribution agreements including pricing and payment terms - Achieved 113% of annual 2012 goal - Number one in new business development

Responsible for the immunology and critical care brand portfolio- Privigen (IVIG)- Carimune (IVIG)- Vivaglobin (subcutaneous immune globulin)- AlbuRX (albumin)- Albuminar (albumin)- Blood plasma productsCoagulation new product market development - New product commercial development of orphan drugs for rare bleeding disorders- Peri-operative bleeding market development and medical education strategies- Key opinion leader relations/development

- Brand Marketing Director – Respiratory/Cardiovascular brandsAsthma/allergy:- Accolate- Pulmicort Turbuhaler- Pulmicor Respules- Rhinocort AquaCardiovascular:- Atacand- Toprol XLAdditional product experience:- Nolvadex- Zoladex- Zomig